(Q42037277)

15 October 2017

Evidence suggesting the presence of a stem cell clone anteceding the acquisition of the JAK2-V617F mutation (English)

1 reference

15 October 2017

R Jamal

1

1 reference

15 October 2017

C Bélisle

2

1 reference

15 October 2017

M-C Lessard

3

1 reference

15 October 2017

J Hébert

4

1 reference

15 October 2017

D-C Roy

5

1 reference

15 October 2017

R Levine

6

1 reference

15 October 2017

L Busque

7

1 reference

15 October 2017

31 January 2008

1 reference

15 October 2017

1 reference

15 October 2017

22

1 reference

15 October 2017

7

1 reference

15 October 2017

1472-1474

1 reference

X-inactivation-based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F-negative ET and MMM patients with clonal hematopoies

15 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640460

Leukemic blasts in transformed JAK2-V617F-positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640460

Polycythemia vera is not initiated by JAK2V617F mutation.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640460

JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disorders.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640460

Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640460

Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640460

Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders

17 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18239619

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Non-leukemic autologous reconstitution after allogeneic bone marrow transplantation for Ph-positive chronic myelogenous leukemia: extended remission preceding eventual relapse

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18239619

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/LEU.2008.6

1 reference

Dimensions Publication ID

15 October 2017

1042773537

0 references

Fatcat ID

release_anmt55szhjhcfg27awdangg47i

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/anmt55szhjhcfg27awdangg47i

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

15 October 2017

PubMed publication ID

18239619

1 reference